Corcept Therapeutics CORT Net debt
Discontinued — last reported Q1 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Corcept Therapeutics’s reported figures.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's net debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Corcept Therapeutics's net debt?
- Corcept Therapeutics (CORT) reported net debt of -$100.35M in Q1 2026.
- How has Corcept Therapeutics's net debt changed year-over-year?
- Corcept Therapeutics's net debt decreased by 19.5% year-over-year, from -$83.98M to -$100.35M.
- What is the long-term trend for Corcept Therapeutics's net debt?
- Over 5 years (2020 to 2025), Corcept Therapeutics's net debt has grown at a 9.4% compound annual growth rate (CAGR), from -$73.64M to -$115.64M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.